Treatment of postoperative nausea and vomiting with single intravenous doses of dolasetron mesylate: A multicenter trial

Anesthesia and Analgesia

Volumn 85, Issue 3, 1997, Pages 546-552

  Kovac, Anthony L ^a,ah   Scuderi, Phillip E ^b   Boerner, Thomas F ^c   Chelly, Jacques E ^d   Goldberg, Michael E ^e   Hantler, Charles B ^f   Hahne, William F ^g   Brown, Robert A ^g   Melson, Timothy I ^h   Graczyk, Sarena G ⁱ   Hickok, Charles B ^j   Jense, Holly ^k   Monk, Terri ^l   Smith, Bradley ^m   Sung, Yung Fong ⁿ   Jahr, Jonathan ^o   Azad, Said ^p   Weiss Jr , F Robert ^q   Barlow, Jared C ^r   Coleman, Robert ^s   Dershwitz, Mark ^t   Conlay, Lydia A ^t   Conrad, William ^u   Solanski, Daneshvari R ^v   Elwood, R J ^w   Twersky, Rebecca ^x   Warner, Mark ^y   Mingus, Melinda ^z   Rigor Sr , Benjamin M ^aa   Angel, John ^ab   Lind, Leonard ^ac   McLeskey, Charles H ^ad   White, Paul ^ae   Williams, Mark S ^af   Covinsky, Joel ^ag   DuBois, Dawn M ^ag   Edwards, Mike ^ag   McGrew, Kathleen ^ag   more..

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g Hoechst Marion Roussel   (United States)

^h Helen Keller Hospital   (United States)

ⁱ Anesthesiologists of Columbia PA   (United States)

^j GEORGE WASHINGTON UNIVERSITY HOSPITAL   (United States)

^k MEDICAL COLLEGE OF GEORGIA   (United States)

^l WASHINGTON UNIVERSITY   (United States)

^m VANDERBILT UNIVERSITY   (United States)

ⁿ EMORY CLINIC   (United States)

^o TULANE UNIVERSITY MEDICAL CENTER   (United States)

^p THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^q UNIVERSITY OF SOUTH ALABAMA MEDICAL CENTER   (United States)

^r Millard Fillmore Surgery Inc   (United States)

^s DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t MASSACHUSETTS GENERAL HOSPITAL   (United States)

^u Internal medicine Department   (United States)

^v UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^w UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^x LONG ISLAND COLLEGE HOSPITAL   (United States)

^y MAYO CLINIC   (United States)

^z MOUNT SINAI MEDICAL CENTER   (United States)

^aa UNIVERSITY OF LOUISVILLE   (United States)

^ab UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^ac UNIVERSITY OF CINCINNATI   (United States)

^ad SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^ae UNIVERSITY OF TEXAS AT DALLAS   (United States)

^af Sorra Research Center   (United States)

^ag SANOFI   (France)

^ah UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOLASETRON MESILATE;

ADULT; AMBULATORY SURGERY; ANTIEMETIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; FEMALE; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; URINE RETENTION; VOMITING;

ADULT; AMBULATORY SURGICAL PROCEDURES; ANESTHESIA, GENERAL; ANTIEMETICS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDOLES; INJECTIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; NAUSEA; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATIONS; QUINOLIZINES; VOMITING;

EID: 0030880763     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199709000-00012     Document Type: Article

References (25)

1. Gralla RJ. Metoclopramide: a review of antiemetic trials. Drugs 1983;25(Suppl 1):63-73.
2. Tigerstedt I, Salmela L, Aromaa U. Double-blind comparison of transdermal scopolamine, droperidol and placebo against postoperative nausea and vomiting. Acta Anaesthesiol Scand 1988; 32:454-7.
3. McKenzie R, Kovac A, O'Conner T, et al. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology 1993;78:21-8.
4. 3 antagonist ondansetron. Anesthesiology 1993;78:15-20.
5. Melson T, Graczyk SG, Hickok C, et al. Prevention of nausea and vomiting with dolasetron after outpatient laparoscopic gynecological surgery [abstract]. Anesthesiology 1995;83:A7.
6. Diemunsch P, Leeser J, Feiss P, et al. Dolasetron mesilate treats established nausea and vomiting after general surgery [abstract]. Anesthesiology 1995;83:A1109.
7. Boxenbaum H, Gillespie T, Heck K, Hahne W. Human dolasetron pharmacokinetics. I. Disposition following single-dose intravenous administration to normal male subjects. Biopharm Drug Dispos 1992;13:693-701.
8. 3 receptors. Drug Dev Res 1993;28:87-93.
9. Harman GS, Omura GA, Ryan K, et al. A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis. Cancer Chemother Pharmacol 1996;38:323-8.
10. 3 antagonist, in cancer patients treated with cisplatin. Am J Clin Oncol 1994; 17:97-102.
11. Shah A, Lanman R, Bhargava V, et al. Pharmacokinetics of dolasetron following single- and multiple-dose administration to normal male subjects. Biopharm Drug Dispos 1995;16:177-89.
12. Hunt TL, Cramer M, Shah A, et al. A double-blind, placebo-controlled, dose-ranging safety and pharmacokinetic evaluation of single-dose intravenous dolasetron mesylate in healthy male volunteers. J Clin Pharmacol 1995;35:705-12.
13. Hesketh P, Navari R, Grote T, et al. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in prevention of acute cisplatin-induced emesis in patients with cancer. J Clin Oncol 1996;14:2242-9.
14. Audhuy B, Cappelaere P, Martin M, et al. A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy. Eur J Cancer 1996; 32:807-13.
15. Gold BS, Kitz DS, Lecky JH, Neuhaus JM. Unanticipated admission to the hospital following ambulatory surgery. JAMA 1989; 262:3008-10.
16. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 1992;27: 162-84.
17. Diemunsch P, Nave S, Meyerson LJ. Evaluation of the antiemetic properties of dolasetron mesilate in gynecological surgery [abstract]. Br J Pharmacol 1994;72:82:A159.
18. Watkins WD, Kovac A, Hickok C, et al. Evaluation of optimally effective IV dose of dolasetron mesylate (DM) for treating established postoperative nausea and vomiting [abstract]. Anesthesiology 1996;85:A17.
19. Fisher DM. Surrogate endpoints: are they meaningful? [editorial]. Anesthesiology 1994;81:795-6.
20. Madej TH, Simpson KH. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting after gynaecological surgery. Br J Anaesth 1986;58:879-83.
21. Mikawa K, Takao Y, Nishina K, et al. The antiemetic efficacy of prophylactic granisetron in gynecologic surgery. Anesth Analg 1995;80:970-4.
22. Palazzo MGA, Strunin L. Anaesthesia and emesis. I. Etiology. Can Anaesth Soc J 1984;31:178-87.
23. Wantanabe H, Hasegawa A, Shinozaki T, et al. Possible cardiac side effects of granisetron, an antiemetic agent, in patients with bone and soft tissue sarcomas receiving cytotoxic chemotherapy. Cancer Chemother Pharmacol 1995;35:278-82.
24. Deleted in proof.
25. Benedict C, Arbogast R, Martin L, et al. Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers. J Cardiovasc Pharmacol 1996;28:53-9.